WO2010130900A3 - Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatases cdc25 - Google Patents
Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatases cdc25 Download PDFInfo
- Publication number
- WO2010130900A3 WO2010130900A3 PCT/FR2010/000371 FR2010000371W WO2010130900A3 WO 2010130900 A3 WO2010130900 A3 WO 2010130900A3 FR 2010000371 W FR2010000371 W FR 2010000371W WO 2010130900 A3 WO2010130900 A3 WO 2010130900A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cdc25 phosphatase
- phosphatase inhibitors
- triaminopyrimidine
- derivatives
- triaminopyrimidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention a pour objet de nouveaux dérivés de triamino-pyrimidine de formule (I) dans laquelle Rl, R2, L, R3, R4a, R5a, R4b, R5b sont des variables. Ces produits ont une activité inhibitrice de phosphatases Cdc25. L'invention concerne également un procédé de synthèse de ces composés ainsi que des compositions thérapeutiques contenant ces produits et leur utilisation comme médicament.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0902352 | 2009-05-15 | ||
FR0902353 | 2009-05-15 | ||
FR0902353A FR2945530A1 (fr) | 2009-05-15 | 2009-05-15 | Derives de tri-amino-pyridine comme inhibiteurs de phosphatases cdc25 |
FR0902352A FR2945532A1 (fr) | 2009-05-15 | 2009-05-15 | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatases cdc25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010130900A2 WO2010130900A2 (fr) | 2010-11-18 |
WO2010130900A3 true WO2010130900A3 (fr) | 2011-04-07 |
Family
ID=42358310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2010/000371 WO2010130900A2 (fr) | 2009-05-15 | 2010-05-12 | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatases cdc25 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010130900A2 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026941A1 (fr) * | 1995-03-02 | 1996-09-06 | Pharmacia & Upjohn Company | PYRIMIDO[4,5-b]INDOLES |
US20060281712A1 (en) * | 2005-06-14 | 2006-12-14 | Chi-Feng Yen | Pyrimidine compounds |
WO2008005538A2 (fr) * | 2006-07-05 | 2008-01-10 | Exelixis, Inc. | Procédés d'utilisation de modulateurs de kinase igf1r et abl |
WO2008031556A2 (fr) * | 2006-09-12 | 2008-03-20 | Ucb Pharma, S.A. | Nouveaux dérivés de la 2-amino-pyrimidine, procédés pour les préparer, compositions pharmaceutiques les contenant |
FR2915747A1 (fr) * | 2007-05-04 | 2008-11-07 | Sod Conseils Rech Applic | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatase cdc25 |
-
2010
- 2010-05-12 WO PCT/FR2010/000371 patent/WO2010130900A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026941A1 (fr) * | 1995-03-02 | 1996-09-06 | Pharmacia & Upjohn Company | PYRIMIDO[4,5-b]INDOLES |
US20060281712A1 (en) * | 2005-06-14 | 2006-12-14 | Chi-Feng Yen | Pyrimidine compounds |
WO2008005538A2 (fr) * | 2006-07-05 | 2008-01-10 | Exelixis, Inc. | Procédés d'utilisation de modulateurs de kinase igf1r et abl |
WO2008031556A2 (fr) * | 2006-09-12 | 2008-03-20 | Ucb Pharma, S.A. | Nouveaux dérivés de la 2-amino-pyrimidine, procédés pour les préparer, compositions pharmaceutiques les contenant |
FR2915747A1 (fr) * | 2007-05-04 | 2008-11-07 | Sod Conseils Rech Applic | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatase cdc25 |
Also Published As
Publication number | Publication date |
---|---|
WO2010130900A2 (fr) | 2010-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011138751A3 (fr) | Dérivés hétérocycliques destinés au traitement de maladies | |
UA110197C2 (ru) | Соединения, эффективные как ингибиторы для ксантиноксидазы, процесса получения таких соединений и фармацевтической композиции, содержащей терапевтически эффективное количество таких соединений. | |
GEP20125537B (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
JO2761B1 (en) | Derivatives of alcohols 1-phenyl-2-pyridinealkyl as inhibitors | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
EP2571876A4 (fr) | Composés hétérocycliques substitués à sept chaînons en tant qu'inhibiteurs de la dipeptidyl-peptidase iv pour le traitement du diabète | |
AU2012204982A8 (en) | 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors | |
WO2010093191A3 (fr) | Nouveaux composés efficaces en tant qu'inhibiteurs de xanthine oxydase, leur procédé de préparation et composition pharmaceutique les contenant | |
WO2011033265A8 (fr) | Composés pharmaceutiques | |
MX343753B (es) | Inhibidores de neprilisina. | |
WO2008145688A3 (fr) | Nouveaux composés | |
WO2008132139A3 (fr) | Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central | |
MX342212B (es) | Inhibidores de neprilisina. | |
MX2013006802A (es) | Inhibidores de neprilisina. | |
PH12015500211A1 (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
SG195319A1 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
JO3577B1 (ar) | صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt | |
GEP20146201B (en) | Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors | |
UA98623C2 (ru) | Соединения диосметина, способ их получения и фармацевтическая композиция, которая их содержит | |
WO2013057013A3 (fr) | Dérivés d'alcools 1-phényl-2-pyridinylalkyliques utilisés comme inhibiteurs de phosphodiestérase | |
WO2009105969A8 (fr) | Analogues d'épothilone, leurs compositions pharmaceutiques, leur utilisation et leurs préparations | |
MX341577B (es) | Derivados biciclicos de pirimidin-urea o carbamato sustituidos con morfolino como inhibidores del blanco de rapamicina de mamifero. | |
IN2012DN01292A (fr) | ||
NZ600453A (en) | Inhibitors of akt activity | |
MX2010004604A (es) | Derivados de pirazol como inhibidores de 5-lo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10723646 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10723646 Country of ref document: EP Kind code of ref document: A2 |